Advertisement

Topics

Search Results for "Abbott Dartford Murex Biotech Ltd"

11:22 EDT 30th September 2016 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Beijing Strong Biotech Grants Technology License to Abbott

Beijing Strong Biotechnologies (BSBE) recently signed a technology license granting Abbott Labs rights to its clinical chemistry testing products, which BSBE currently manufactures in China. Initially...

Johnson & Johnson To Acquire Abbott's Vision Care Business For $4.33 Bln

MILWAUKEE (dpa-AFX) - Johnson & Johnson (JNJ) announced a definitive agreement to acquire Abbott Medical Optics, a subsidiary of Abbott Laboratories, for $4.325 billion in cash. Abbott Medical Opt...

Abbott enters systems integration deal with Diasend

A collaboration deal has been reached by Abbott and Diasend to allow a cloud-based connection between Abbott's LibreLink syst -More- 

BRIEF-Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 bln

* Net impact of this transaction is not expected to impact Abbott's overall targeted ongoing earnings per share in 2017.

Alere drags Abbott to court over $5.8 bln deal

Aug 26 (Reuters) - Alere Inc, which has agreed to be bought by Abbott Laboratories, said on Friday it filed a complaint, seeking to compel Abbott to obtain all antitrust approvals required to complete...

UPDATE 1-Alere drags Abbott to court over $5.8 bln deal

Aug 26 (Reuters) - Diagnostic-testing company Alere Inc , which has agreed to be bought by Abbott Laboratories , said on Friday it filed a lawsuit, seeking to compel Abbott to obtain all antitrust app...

Abbott deal for St. Jude spurs company split talk

When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Mil...

Abbott to Present at Wells Fargo Healthcare Conference

ABBOTT PARK, Ill., Aug. 24, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Wells Fargo 2016 Healthcare Conference on Wednesday, Sept. 7, 2016. Brian Yoor, senior vice president, fina...

Matching PubMed Articles

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015...

Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.

On-treatment hepatitis C virus (HCV) kinetics play an invaluable role in evaluating the efficacy of interferon-based therapies. However, the importance of HCV RNA monitoring has not been well discusse...

Response to proposed research to reverse brain death: more than regulatory failure.

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration be...

Erratum: When biotech goes bad.

Second-quarter biotech job picture.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement